RoslinCT Email Format

Biotechnology ResearchScotland, United Kingdom201-500 Employees

RoslinCT is a global contract development and manufacturing organization focused on advanced cell therapies. It delivers end-to-end CDMO services, including process development, analytical development, and cGMP manufacturing for both autologous and allogeneic cell therapies, as well as iPSC line development and gene editing. Established in 2005 and rooted in the Roslin Institute’s Dolly the Sheep work, the company has achieved milestones such as producing clinical-grade human pluripotent stem cells and advancing a CRISPR-edited stem cell-based therapy toward marketing authorization. 

Based in Edinburgh, Scotland, with additional facilities in Hopkinton, Massachusetts, RoslinCT supports partners seeking to move therapies from development to commercialization. A recent development is the expansion of the Hopkinton site to add cleanroom space to support production of both autologous and allogeneic products.

Sign up for free to view info

Company overview Employee directory